ReviewCureus2026
The Global Epidemiology of Antimicrobial Resistance: Trends, Determinants, and Public Health Implications.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- National surveillance of antimicrobial resistance in Iran using IAMR software: A hospital-based study.New microbes and new infections · 2026Article
- Investigation of Biofilm Formation and Antimicrobial Resistance in Bacteria Isolated from Hospital Medical Devices.Microorganisms · 2026Article
- Bacteriophage therapy for multidrug-resistant bacterial infections: recent advances, clinical evidence, and translational challenges.Archives of microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) represents one of the most pressing global health and development challenges of the twenty-first century, threatening the effectiveness of antimicrobial therapies and undermining the clinical management of infectious diseases worldwide. The increasing prevalence of resistant pathogens undermines progress in disease control, surgery, and critical care, and poses severe socioeconomic and public health consequences. This narrative review synthesizes multidisciplinary evidence to examine the global trends, determinants, and implications of AMR through an integrated One Health framework encompassing human, animal, and environmental systems. The review draws upon peer-reviewed literature, international surveillance data, and policy reports published between 2015 and 2025 to provide a comprehensive understanding of resistance patterns and drivers. Findings reveal that resistance arises from an interplay of inappropriate antimicrobial use, insufficient infection prevention, environmental contamination, and weak governance, with the heaviest burden in low- and middle-income countries. Despite global action plans and stewardship initiatives, progress remains constrained by inequitable resources, limited diagnostics, and fragmented implementation. Strengthening surveillance systems, fostering responsible antimicrobial use, promoting research and vaccine development, and embedding One Health principles in policy are vital to reversing current trends. Coordinated global action, equitable investment, and sustained political commitment are essential to preserve antimicrobial efficacy and ensure the resilience of health systems worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.